Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
37.90
+1.70 (4.70%)
At close: Jun 26, 2026, 4:00 PM EDT
37.15
-0.75 (-1.98%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Agios Pharmaceuticals Employees
As of December 31, 2025, Agios Pharmaceuticals had 540 total employees, including 539 full-time and 1 part-time employees. The number of employees increased by 52 or 10.66% compared to the previous year.
Employees
540
Change (1Y)
52
Growth (1Y)
10.66%
Revenue / Employee
$122,311
Profits / Employee
-$782,598
Market Cap
2.25B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Vericel | 398 |
| Intellia Therapeutics | 377 |
| Ocular Therapeutix | 325 |
| Nurix Therapeutics | 317 |
| Immunome | 206 |
| Kodiak Sciences | 130 |
| Aurinia Pharmaceuticals | 128 |
AGIO News
- 13 days ago - Agios Pharmaceuticals price target raised to $54 from $50 at H.C. Wainwright - TheFly
- 13 days ago - Agios Pharmaceuticals presented results from Phase 3 trial of mitapivat - TheFly
- 15 days ago - Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease - GlobeNewsWire
- 15 days ago - Agios Pharmaceuticals Transcript: EHA 2026 - Transcripts
- 15 days ago - Agios Pharmaceuticals Slides: FY 2026 - Filings
- 17 days ago - Agios Pharmaceuticals price target lowered to $31 from $36 at JPMorgan - TheFly
- 27 days ago - Agios Pharmaceuticals Transcript: Status update - Transcripts
- 27 days ago - Agios Pharmaceuticals Slides: Status update - Filings